Getagraph.com logo
NASDAQ Composite: ( -0.71%) 17 733
S&P 500 Futures
(0.05%) 5 524.50 points
Dow Jones Futures
(0.17%) 39 535 points
Nasdaq Futures
(-0.02%) 19 923 points
Oil
(0.64%) $82.06
Gas
(-0.92%) $2.58
Gold
(-0.06%) $2 338.30
Silver
(1.00%) $29.53
Platinum
(-0.71%) $994.80
USD/EUR
(-0.41%) $0.929
USD/NOK
(-0.45%) $10.63
USD/GBP
(-0.20%) $0.789
USD/RUB
(1.78%) $87.25

Aktualne aktualizacje dla Sarepta Therapeutics, [0L35.L]

Giełda: London Stock Exchange Sektor: Healthcare Branża: Medical - Pharmaceuticals
Ostatnio aktualizowano28 birž. 2024 @ 20:55
25% discount on Stockinvest.us - Use code: Podcast

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 20:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Dzisiejszy wolumen 351
Średni wolumen 424
Kapitalizacja rynkowa 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Następna data zysków ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $1.006 (0.64%)